Alexion Pharma LLC (TRMS)

Stock chart
Ticker: TRMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2015-06-09 2015-06-08 S Sale

Williams Glen

SVP, Technical Operations

Officer
2,520 -8.8%
215.72
USD 543,614
2,520 -8.8% 215.72 USD 543,614
2015-06-09 2015-06-08 S Sale

Williams Glen

SVP, Technical Operations

Officer
10,396 -26.7%
214.72
USD 2,232,229
10,396 -26.7% 214.72 USD 2,232,229
2015-05-08 2015-05-06 PS Planned sale

Williams Glen

SVP, Technical Operations

Officer
100 -17.6%
215.26
USD 21,526
100 -17.6% 215.26 USD 21,526
2015-05-08 2015-05-06 PS Planned sale

Williams Glen

SVP, Technical Operations

Officer
100 -15.0%
206.97
USD 20,697
100 -15.0% 206.97 USD 20,697
2015-05-08 2015-05-06 PS Planned sale

Williams Glen

SVP, Technical Operations

Officer
400 -37.5%
206.27
USD 82,508
400 -37.5% 206.27 USD 82,508
2015-05-08 2015-05-06 PS Planned sale

Williams Glen

SVP, Technical Operations

Officer
400 -27.2%
204.94
USD 81,976
400 -27.2% 204.94 USD 81,976
2015-05-08 2015-05-06 PS Planned sale

Williams Glen

SVP, Technical Operations

Officer
666 -31.2%
203.99
USD 135,857
666 -31.2% 203.99 USD 135,857
2015-04-29 2015-04-27 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
10,000 -64.0%
110.00
USD 1,100,000
10,000 -64.0% 110.00 USD 1,100,000
2015-04-17 2015-04-15 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
10,000 -39.0%
105.00
USD 1,050,000
10,000 -39.0% 105.00 USD 1,050,000
2015-04-09 2015-04-08 PS Planned sale

Williams Glen

SVP, Technical Operations

Officer
39,863 -98.8%
96.08
USD 3,830,037
39,863 -98.8% 96.08 USD 3,830,037
2015-04-09 2015-04-07 PS Planned sale

Williams Glen

SVP, Technical Operations

Officer
2,769 -85.5%
96.04
USD 265,935
2,769 -85.5% 96.04 USD 265,935
2015-04-08 2015-04-06 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
29,503 -65.4%
93.76
USD 2,766,201
29,503 -65.4% 93.76 USD 2,766,201
2015-03-13 2015-03-11 PS Planned sale

Heberlig Chris

SVP, Finance and Business Ops.

Officer
300 -43.5%
105.74
USD 31,722
300 -43.5% 105.74 USD 31,722
2015-03-13 2015-03-11 PS Planned sale

Heberlig Chris

SVP, Finance and Business Ops.

Officer
1,510 -68.6%
104.57
USD 157,901
1,510 -68.6% 104.57 USD 157,901
2015-03-13 2015-03-11 PS Planned sale

Heberlig Chris

SVP, Finance and Business Ops.

Officer
3,290 -59.9%
103.55
USD 340,680
3,290 -59.9% 103.55 USD 340,680
2015-03-13 2015-03-11 PS Planned sale

Heberlig Chris

SVP, Finance and Business Ops.

Officer
900 -14.1%
102.46
USD 92,214
900 -14.1% 102.46 USD 92,214
2015-03-13 2015-03-11 PS Planned sale

Heberlig Chris

SVP, Finance and Business Ops.

Officer
600 -8.6%
101.38
USD 60,828
600 -8.6% 101.38 USD 60,828
2015-03-13 2015-03-11 PS Planned sale

Heberlig Chris

SVP, Finance and Business Ops.

Officer
900 -11.4%
100.44
USD 90,396
900 -11.4% 100.44 USD 90,396
2015-02-19 2015-02-17 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,842 -100.0%
101.69
USD 187,313
1,842 -100.0% 101.69 USD 187,313
2015-02-19 2015-02-17 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
16,716 -90.1%
100.74
USD 1,683,970
16,716 -90.1% 100.74 USD 1,683,970
2015-02-19 2015-02-17 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
14,750 -44.3%
99.97
USD 1,474,558
14,750 -44.3% 99.97 USD 1,474,558
2015-02-19 2015-02-17 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
8,989 -21.3%
98.85
USD 888,563
8,989 -21.3% 98.85 USD 888,563
2015-01-09 2015-01-07 B Purchase

BAKER JULIAN

Non-Executive Director Large shareholder
1,000,000 +12.2%
94.19
USD 94,190,000
1,000,000 +12.2% 94.19 USD 94,190,000
2015-01-09 2015-01-07 B Purchase

BAKER FELIX

Non-Executive Director Large shareholder
1,000,000 +12.2%
94.19
USD 94,190,000
1,000,000 +12.2% 94.19 USD 94,190,000
2014-12-30 2014-12-29 PS Planned sale

Heberlig Chris

Group Vice President, Finance

Officer
300 -49.7%
93.04
USD 27,912
300 -49.7% 93.04 USD 27,912
2014-12-30 2014-12-29 PS Planned sale

Heberlig Chris

Group Vice President, Finance

Officer
1,156 -65.7%
92.10
USD 106,468
1,156 -65.7% 92.10 USD 106,468
2014-12-30 2014-12-29 PS Planned sale

Heberlig Chris

Group Vice President, Finance

Officer
2,844 -61.8%
91.34
USD 259,771
2,844 -61.8% 91.34 USD 259,771
2014-12-30 2014-12-29 PS Planned sale

Heberlig Chris

Group Vice President, Finance

Officer
1,800 -28.1%
89.90
USD 161,820
1,800 -28.1% 89.90 USD 161,820
2014-12-19 2014-12-17 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
26,960 -96.3%
90.06
USD 2,428,018
26,960 -96.3% 90.06 USD 2,428,018
2014-12-19 2014-12-17 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
4,488 -13.8%
87.26
USD 391,623
4,488 -13.8% 87.26 USD 391,623
2014-12-19 2014-12-17 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
13,536 -29.4%
87.55
USD 1,185,077
13,536 -29.4% 87.55 USD 1,185,077
2014-12-19 2014-12-17 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
5,016 -9.8%
87.25
USD 437,646
5,016 -9.8% 87.25 USD 437,646
2014-10-30 2014-10-30 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
22,904 -100.0%
80.11
USD 1,834,839
22,904 -100.0% 80.11 USD 1,834,839
2014-10-30 2014-10-28 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,000 -100.0%
80.00
USD 80,000
1,000 -100.0% 80.00 USD 80,000
2014-10-30 2014-10-28 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,500 -60.0%
80.00
USD 120,000
1,500 -60.0% 80.00 USD 120,000
2014-09-19 2014-09-19 PS Planned sale

Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
790 -58.4%
65.24
USD 51,540
790 -58.4% 65.24 USD 51,540
2014-09-18 2014-09-17 PS Planned sale

Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
4,200 -88.2%
65.06
USD 273,252
4,200 -88.2% 65.06 USD 273,252
2014-09-18 2014-09-16 PS Planned sale

Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
9,379 -94.3%
65.01
USD 609,729
9,379 -94.3% 65.01 USD 609,729
2014-09-04 2014-09-02 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
300 -1.2%
72.88
USD 21,864
300 -1.2% 72.88 USD 21,864
2014-09-04 2014-09-02 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
700 -2.6%
71.96
USD 50,372
700 -2.6% 71.96 USD 50,372
2014-09-04 2014-09-02 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
400 -1.5%
70.50
USD 28,200
400 -1.5% 70.50 USD 28,200
2014-09-04 2014-09-02 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
8,600 -24.2%
69.88
USD 600,968
8,600 -24.2% 69.88 USD 600,968
2014-06-26 2014-06-25 PS Planned sale

Williams Glen

SVP, Technical Operations

Officer
700 -72.5%
108.02
USD 75,614
700 -72.5% 108.02 USD 75,614
2014-06-24 2014-06-20 PS Planned sale

Quart Barry D

Non-Executive Director
1,375 -100.0%
100.00
USD 137,500
1,375 -100.0% 100.00 USD 137,500
2014-06-19 2014-06-17 PS Planned sale

Quart Barry D

Non-Executive Director
1,000 -100.0%
90.00
USD 90,000
1,000 -100.0% 90.00 USD 90,000
2014-06-16 2014-06-12 PS Planned sale

Quart Barry D

Non-Executive Director
1,000 -100.0%
83.31
USD 83,310
1,000 -100.0% 83.31 USD 83,310
2014-06-12 2014-06-11 PS Planned sale

Goldberg Mark Alan

EVP, Medical & Reg. Strategy

Officer
21,597 -97.9%
80.00
USD 1,727,760
21,597 -97.9% 80.00 USD 1,727,760
2014-05-20 2014-05-16 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
200 -100.0%
83.46
USD 16,692
200 -100.0% 83.46 USD 16,692
2014-05-20 2014-05-16 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,591 -88.8%
82.71
USD 131,592
1,591 -88.8% 82.71 USD 131,592
2014-05-20 2014-05-16 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
8,136 -82.0%
81.75
USD 665,118
8,136 -82.0% 81.75 USD 665,118
2014-04-03 2014-04-01 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
1,050 -6.3%
85.76
USD 90,048
1,050 -6.3% 85.76 USD 90,048
2014-04-03 2014-04-01 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
4,746 -22.3%
84.72
USD 402,081
4,746 -22.3% 84.72 USD 402,081
2014-04-03 2014-04-01 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
3,529 -14.2%
83.50
USD 294,672
3,529 -14.2% 83.50 USD 294,672
2014-04-03 2014-04-01 PS Planned sale

Quinn Anthony

EVP, CMO & Head of R&D

Officer
10,675 -30.1%
82.80
USD 883,890
10,675 -30.1% 82.80 USD 883,890
2014-03-14 2014-03-12 PS Planned sale

Heberlig Chris

Group Vice President, Finance

Officer
3,037 -94.1%
99.08
USD 300,906
3,037 -94.1% 99.08 USD 300,906
2014-03-14 2014-03-12 PS Planned sale

Heberlig Chris

Group Vice President, Finance

Officer
3,933 -54.9%
98.49
USD 387,361
3,933 -54.9% 98.49 USD 387,361
2014-03-14 2014-03-12 PS Planned sale

Heberlig Chris

Group Vice President, Finance

Officer
700 -8.9%
96.75
USD 67,725
700 -8.9% 96.75 USD 67,725
2014-03-07 2014-03-06 B Purchase

BAKER FELIX

Non-Executive Director Large shareholder
9,031 +4.5%
105.75
USD 955,028
9,031 +4.5% 105.75 USD 955,028
2014-03-07 2014-03-06 B Purchase

BAKER JULIAN

Non-Executive Director Large shareholder
9,031 +4.5%
105.75
USD 955,028
9,031 +4.5% 105.75 USD 955,028
2014-03-07 2014-03-06 B Purchase

BAKER FELIX

Non-Executive Director Large shareholder
365,969 +4.7%
105.75
USD 38,701,222
365,969 +4.7% 105.75 USD 38,701,222
2014-03-07 2014-03-06 B Purchase

BAKER JULIAN

Non-Executive Director Large shareholder
365,969 +4.7%
105.75
USD 38,701,222
365,969 +4.7% 105.75 USD 38,701,222
2014-02-20 2014-02-18 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
894 -100.0%
104.22
USD 93,173
894 -100.0% 104.22 USD 93,173
2014-02-20 2014-02-18 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,745 -66.1%
103.05
USD 179,822
1,745 -66.1% 103.05 USD 179,822
2014-02-20 2014-02-18 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
3,207 -54.9%
102.18
USD 327,691
3,207 -54.9% 102.18 USD 327,691
2014-02-20 2014-02-18 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
3,081 -34.5%
101.14
USD 311,612
3,081 -34.5% 101.14 USD 311,612
2014-02-20 2014-02-18 PS Planned sale

BOESS CARSTEN

SVP, Chief Financial Officer

Officer
1,000 -10.1%
100.07
USD 100,070
1,000 -10.1% 100.07 USD 100,070
2014-01-30 2014-01-29 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
400 -28.0%
91.58
USD 36,632
400 -28.0% 91.58 USD 36,632
2014-01-30 2014-01-29 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
1,502 -51.2%
90.85
USD 136,457
1,502 -51.2% 90.85 USD 136,457
2014-01-30 2014-01-29 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
5,600 -65.6%
89.27
USD 499,912
5,600 -65.6% 89.27 USD 499,912
2014-01-30 2014-01-29 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
18,652 -68.6%
88.31
USD 1,647,158
18,652 -68.6% 88.31 USD 1,647,158
2014-01-30 2014-01-29 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
24,817 -47.7%
87.19
USD 2,163,794
24,817 -47.7% 87.19 USD 2,163,794
2014-01-30 2014-01-28 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
812 -44.1%
90.10
USD 73,161
812 -44.1% 90.10 USD 73,161
2014-01-30 2014-01-28 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
8,402 -82.0%
88.95
USD 747,358
8,402 -82.0% 88.95 USD 747,358
2014-01-30 2014-01-28 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
32,609 -76.1%
88.38
USD 2,881,983
32,609 -76.1% 88.38 USD 2,881,983
2014-01-30 2014-01-28 PS Planned sale

Patel Sanj K

President & CEO

Executive Director
9,506 -18.2%
87.16
USD 828,543
9,506 -18.2% 87.16 USD 828,543
// ... existing code ... // ... rest of the file ...